Compound ID | 567
ABI200
Class: Bacteriophage and/or bacteriophage-derived product
| Agent Type: | Direct acting; Bacteriophage or bacteriphage-derived product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | A fusion protein with multiple lytic domains to lyse Gram-positive cell wall |
| Description: | Designed to overcome multidrug resistant Gram-positive bacterial strains in veterinary medicine |
| Institute where first reported: | AdRem Biotech, USA |
| Year first mentioned: | 2009 |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.